— Topic
Triple-Negative Breast Cancer
2 briefings
Triple-Negative Breast Cancer
Targeting the Untargetable: New Antibody Disrupts Key Protein in Aggressive Breast Cancer
Researchers at MUSC Hollings Cancer Center have developed an antibody targeting the SFRP2 protein, opening a new front in the battle against triple-negative breast cancer.
Dec 15, 2025
4 min read
Triple-Negative Breast Cancer
Breakthrough Antibody Targeting SFRP2 Protein Halts Aggressive Breast Cancer in Preclinical Models
Researchers at MUSC Hollings Cancer Center have developed a humanized antibody that neutralizes a key protein driving tumor growth and metastasis in triple-negative breast cancer.
Dec 14, 2025
3 min read